EirGen Pharma Eir-012 license submission in South Africa

EirGen Pharma are pleased to announce that their treatment for early stage breast cancer  "Eir-012" was submitted for approval to the South Africa Health Authority in July 2010.

EirGen Pharma is a pharmaceutical company based in Waterford, Ireland. Using its purpose built high containment facility; the company specialises in the development, registration and manufacture of high potency solid dose products for global markets.